These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26239039)

  • 21. Overview and findings from the religious orders study.
    Bennett DA; Schneider JA; Arvanitakis Z; Wilson RS
    Curr Alzheimer Res; 2012 Jul; 9(6):628-45. PubMed ID: 22471860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
    Hill NL; Mogle J
    BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lifecourse social conditions and racial and ethnic patterns of cognitive aging.
    Glymour MM; Manly JJ
    Neuropsychol Rev; 2008 Sep; 18(3):223-54. PubMed ID: 18815889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular cognitive impairment.
    Gilbert DT
    West Indian Med J; 2007 Dec; 56(6):479-80. PubMed ID: 18646488
    [No Abstract]   [Full Text] [Related]  

  • 25. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related differences in cognition across the adult lifespan in autism spectrum disorder.
    Lever AG; Geurts HM
    Autism Res; 2016 Jun; 9(6):666-76. PubMed ID: 26333004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease.
    Mungas D; Reed BR; Jagust WJ; DeCarli C; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
    Neurology; 2002 Sep; 59(6):867-73. PubMed ID: 12297568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ageing and Cognition.
    Juan SMA; Adlard PA
    Subcell Biochem; 2019; 91():107-122. PubMed ID: 30888651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
    Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
    Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.
    Negash S; Bennett DA; Wilson RS; Schneider JA; Arnold SE
    Curr Alzheimer Res; 2011 Jun; 8(4):336-40. PubMed ID: 21222592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.
    Riley KP; Snowdon DA; Desrosiers MF; Markesbery WR
    Neurobiol Aging; 2005 Mar; 26(3):341-7. PubMed ID: 15639312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A purpose-oriented life: is it potentially neuroprotective?
    Geda YE
    Arch Neurol; 2010 Aug; 67(8):1010-1. PubMed ID: 20697053
    [No Abstract]   [Full Text] [Related]  

  • 34. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Vemuri P; Lesnick TG; Przybelski SA; Knopman DS; Preboske GM; Kantarci K; Raman MR; Machulda MM; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Rocca WA; Roberts RO; Petersen RC; Jack CR
    Brain; 2015 Mar; 138(Pt 3):761-71. PubMed ID: 25595145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
    Schönknecht P; Pantel J; Kruse A; Schröder J
    Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting the rate of cognitive decline in aging and early Alzheimer disease.
    Adak S; Illouz K; Gorman W; Tandon R; Zimmerman EA; Guariglia R; Moore MM; Kaye JA
    Neurology; 2004 Jul; 63(1):108-14. PubMed ID: 15249619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease.
    Wilson RS; McCann JJ; Li Y; Aggarwal NT; Gilley DW; Evans DA
    Am J Psychiatry; 2007 Jun; 164(6):910-5. PubMed ID: 17541050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of cerebrovascular disease related cognitive decline.
    Qiu C; Fratiglioni L
    Int Psychogeriatr; 2003; 15 Suppl 1():105-10. PubMed ID: 16191225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.